Table 2. Categorization of sexual health indicators identified from the indicator sources of the SDGs10 and the Global Health Observatory11.
| Component, source | Indicatora | Type |
|---|---|---|
| Sexually transmitted infections including HIV | ||
| SDG | Number of new HIV infections per 1 000 uninfected population, by sex, age and key population (3.3.1) | Incidence |
| GHO | HIV – Estimated antiretroviral therapy coverage among children | Treatment |
| GHO | HIV – Estimated antiretroviral therapy coverage among people living with HIV (%) | Treatment |
| GHO | HIV – Estimated number of children living with HIV | Prevalence |
| GHO | HIV – Estimated number of pregnant women living with HIV | Prevalence |
| GHO | HIV – Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission | Treatment |
| GHO | HIV – New HIV infections (per 1 000 uninfected population) | Incidence |
| GHO | HIV – New HIV infections among adults 15–24 years old (per 1 000 uninfected population) | Incidence |
| GHO | HIV – Number of new HIV infections | Incidence |
| GHO | HIV – Number of people (all ages) living with HIV | Prevalence |
| GHO | HIV – Number of people dying from HIV-related causes | Deaths |
| GHO | HIV – Number of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission | Treatment |
| GHO | HIV – People who received HIV testing and counselling | Testing |
| GHO | HIV – Prevalence of HIV among adults aged 15 to 49 years (%) | Prevalence |
| GHO | HIV – Reported number of children receiving antiretroviral therapy | Treatment |
| GHO | HIV – Reported number of people receiving antiretroviral therapy | Treatment |
| GHO | HIV – Reported number of people receiving antiretroviral therapy, month and year of report | Treatment |
| GHO | HIV – testing and counselling facilities | Health system |
| GHO | Testing and counselling facilities, estimated number per 100 000 adult population | Health system |
| GHO | Testing and counselling facilities, reported number | Health system |
| GHO | Testing and counselling facilities, reporting period | Health system |
| GHO | Population aged 15–24 years with comprehensive correct knowledge of HIV/AIDS (%) | Prevention |
| GHO | Prevalence of condom use by adults during higher-risk sex (15–49 years) (%) | Prevention |
| GHO | Women accessing antenatal care (ANC) services who were tested for syphilis (%), reported | Testing |
| GHO | Antenatal care attendees positive for syphilis who received treatment (%), reported | Treatment |
| GHO | Antenatal care attendees who were positive for syphilis (%), reported | Prevalence |
| GHO | HIV-positive TB patients on ART (antiretroviral therapy) (%) | Treatment |
| GHO | TB patients with known HIV status (%) | Testing |
| GHO | Tested TB patients HIV-positive (%) | Prevalence |
| GHO | Treatment success rate: HIV-positive TB cases | Treatment |
| GHO | Hepatitis - new infections | Incidence |
| GHO | Hepatitis - number of chronic hepatitis B-infected persons treated | Treatment |
| GHO | Hepatitis - number of persons initiated hepatitis C treatment, latest year and cumulative over a period of years | Treatment |
| GHO | Hepatitis- diagnosis coverage of chronic hepatitis (HBV and HCV) as a percentage of infected | Prevalence |
| GHO | STI: Incident cases of chlamydia in 15–49 year olds (in thousands) | Incidence |
| GHO | STI: Incident cases of chlamydia in 15–49 year olds (per 1 000) | Incidence |
| GHO | STI: Incident cases of gonorrhoea in 15–49 year olds (in thousands) | Incidence |
| GHO | STI: Incident cases of gonorrhoea in 15–49 year olds (per 1 000) | Incidence |
| GHO | STI: Incident cases of syphilis in 15–49 year olds (in thousands) | Incidence |
| GHO | STI: Incident cases of trichomoniasis in 15–49 year olds (in thousands) | Incidence |
| GHO | STI: Incident cases of trichomoniasis in 15–49 year olds (per 1 000) | Incidence |
| GHO | STI: Incident rate of active syphilis (per 1 000) | Incidence |
| GHO | STI: Prevalence of active syphilis in 15–49 year olds (%) | Prevalence |
| GHO | STI: Prevalence of chlamydia in15–49 year olds (%) | Prevalence |
| GHO | STI: Prevalence of gonorrhoea in 15–49 year olds (%) | Prevalence |
| GHO | STI: Prevalence of trichomoniasis in 15–49 year olds (%) | Prevalence |
| GHO | STI: Prevalent cases of active syphilis (in thousands) | Prevalence |
| GHO | STI: Prevalent cases of chlamydia in 15–49 year olds (in thousands) | Prevalence |
| GHO | STI: Prevalent cases of gonorrhoea in 15–49 year olds (in thousands) | Prevalence |
| GHO | STI: Prevalent cases of trichomoniasis in 15–49 year olds (in thousands) | Prevalence |
| Cancers of the reproductive system | ||
| GHO | HPV immunization coverage estimates among primary target cohort (9–14 years old girls) (%) | Prevention |
| GHO | Prevalence of cervical cancer screening among women aged 30–49 years (%) | Testing |
| GHO | Most widely used screening method in national cervical cancer screening programme | Health system |
| GHO | Type of national cervical cancer screening programme | Health system |
| GHO | Existence of national screening programme for breast cancer | Testing |
| Gender-based violence including violence against women | ||
| SDG | Proportion of ever-partnered women and girls aged 15 years and older subjected to physical, sexual or psychological violence by a current or former intimate partner in the previous 12 months, by form of violence and by age (5.2.1) | Incidence |
| SDG | Proportion of women and girls aged 15 years and older subjected to sexual violence by persons other than an intimate partner in the previous 12 months, by age and place of occurrence (5.2.2) | Incidence |
| SDG | Proportion of persons victim of physical or sexual harassment, by sex, age, disability status and place of occurrence, in the previous 12 months (11.7.2) | Incidence |
| SDG | Proportion of population subjected to (a) physical violence, (b) psychological violence and (c) sexual violence in the previous 12 months (16.1.3) | Incidence |
| SDG | Proportion of young women and men aged 18–29 years who experienced sexual violence by age 18 (16.2.3) | Prevalence |
| GHO | Intimate partner violence prevalence among ever-partnered women in the previous 12 months (%) | Incidence |
| GHO | Intimate partner violence prevalence among ever-partnered women in their lifetime (%) | Prevalence |
| GHO | Intimate partner violence: Extent of implementation of dating violence prevention programmes | Prevention |
| GHO | Lifetime prevalence of child sexual abuse (%) | Prevalence |
| GHO | Non-partner sexual violence prevalence (%) | Prevalence |
| GHO | Proportion of ever-partnered women and girls aged 15–49 years subjected to physical and/or sexual violence by a current or former intimate partner in the previous 12 months | Incidence |
| Comprehensive sexuality education | ||
| SDG | Number of countries with laws and regulations that guarantee full and equal access to women and men aged 15 years and older to sexual and reproductive health care, information and education (5.6.2) | Laws and policies |
| Sexual health and well-being | ||
| SDG | Proportion of women aged 20–24 years who were married or in a union before age 15 and before age 18 (5.3.1) | Prevalence |
| SDG | Proportion of girls and women aged 15–49 years who have undergone female genital mutilation, by age (5.3.2) | Prevalence |
| SDG | Proportion of women aged 15–49 years who make their own informed decisions regarding sexual relations, contraceptive use and reproductive health care (5.6.1) | Well-being |
| SDG | Number of countries with laws and regulations that guarantee full and equal access to women and men aged 15 years and older to sexual and reproductive health care, information and education (5.6.2) | Laws and policies |
| GHO | Proportion of women aged 20–24 years who were married or in a union by age 15 (%) | Prevalence |
| GHO | Proportion of women aged 20–24 years who were married or in a union by age 18 (%) | Prevalence |
| GHO | Proportion of girls and women aged 15–49 years who have undergone female genital mutilation/cutting (%) | Prevalence |
AIDS: acquired immunodeficiency syndrome; GHO: Global Health Observatory; HBV: hepatitis B virus; HCV: hepatitis C virus; HIV: human immunodeficiency virus; HPV: human papillomavirus; SDG: sustainable development goals; STI: sexually transmitted infection.
a Text as given in source. For SDG indicators, the numbers in the parentheses are the indicator numbers.
Note: we based the components on the nine interventions outlined in Accelerate progress – sexual and reproductive health and rights for all: report of the Guttmacher–Lancet Commission.9